Literature DB >> 18605425

Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.

G Pearson1, F Dewey, G Klein, G Henle, W Henle.   

Abstract

The neutralization of Epstein-Barr virus (EBV) infectivity by sera with known antibody activities against EBV-associated antigens was investigated in experimentally infected Raji and RPMI 64-10 cells. Antibodies against EBV-induced cell-membrane antigens were apparently responsible for neutralization of viral infectivity. Antibodies against EBV capsid antigens and EBV-induced early antigens were not involved. The implication of these results on the relationship of the membrane antigens to the infectious virus particle is discussed.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 18605425

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


  13 in total

1.  Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.

Authors:  A Douglas Wilson; Andrew J Morgan
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 2.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

Review 4.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Location of antigens associated with bovine leukemia virus.

Authors:  M Onuma; D M Driscoli; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

Review 6.  Immunological studies on Burkitt's lymphoma.

Authors:  G Klein
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

Review 7.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  Relation between common antigen and membrane antigens associated with Marek's disease herpesvirus and turkey herpesvirus infections.

Authors:  M Onuma; T Mikami; T T Hayashi
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

Authors:  Junji Sashihara; Peter D Burbelo; Barbara Savoldo; Theodore C Pierson; Jeffrey I Cohen
Journal:  Virology       Date:  2009-07-07       Impact factor: 3.616

10.  Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.

Authors:  K Takada; S Fujiwara; S Yano; T Osato
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.